SA
VERV

Sanctuary Advisors’s Verve Therapeutics VERV Stock Holding History

Sanctuary Advisors’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,665
Closed -$131K – 2552
2025
Q2 		$131K Buy
+11,665
New +$66.5K ﹤0.01% 2238

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Sanctuary Advisors's VERV Position: Q3 2025 in Review

Sanctuary Advisors sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 11,665 shares — an estimated $131K sold.

Sanctuary Advisors first reported a position in VERV in Q2 2025 and held it in 1 quarter. The position peaked at $131K in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Sanctuary Advisors reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Sanctuary Advisors sold 11,665 Verve Therapeutics shares in Q3 2025, an estimated $131K.
  • Sanctuary Advisors first reported a position in Verve Therapeutics in Q2 2025 and held it in 1 quarter.
  • Sanctuary Advisors's Verve Therapeutics position peaked at $131K in Q2 2025.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Sanctuary Advisors's 13F filing for Q3 2025, filed 6 Jan 2026.